Obesity-related type 2 diabetes is a progressive disorder and most patients eventually require treatment with insulin to control blood glucose levels as β cells in the pancreas lose their ability to produce insulin (Kahn and Hull, 2006). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.